![]() |
VOOZH | about |
*615874
Table of Contents
Alternative titles; symbols
HGNC Approved Gene Symbol: RSL1D1
Cytogenetic location: 16p13.13 Genomic coordinates (GRCh38) : 16:11,833,850-11,851,542 (from NCBI)
RSL1D1 is a nucleolar protein that regulates mRNA translation (Ma et al., 2008).
By suppressive subtractive hybridization to identify proteins downregulated with replicative senescence in 2BS human diploid fibroblasts, followed by PCR amplification, Ma et al. (2008) cloned RSL1D1, which they called CSIG. The deduced 490-amino acid protein has an N-terminal ribosomal L1 (see MRPL1, 611821) domain and a C-terminal lysine-rich domain. Northern blot analysis detected variable CSIG expression in most human tissues examined, with highest expression in heart, skeletal muscle, and placenta, and little to no expression in brain, colon, and thymus. Endogenous CSIG localized predominantly to the nucleolus in 2BS and HeLa cells and fractionated with HEK293 cell polysomes. Western blot analysis detected CSIG at an apparent molecular mass of 55 kD.
Ma et al. (2008) determined that the RSL1D1 gene contains 9 exons and spans 5.1 kb.
Ma et al. (2008) reported that the RSL1D1 gene maps to chromosome 16p13.
UPA (PLAU; 191840) is an extracellular matrix protease involved in cell migration. Using a yeast 1-hybrid screen and EMSA, Tong et al. (2005) found that RSL1D1, or PBK1, bound an enhancer region in the UPA promoter between 2 AP1 (see 165160) sites. Overexpression and knockdown experiments with 95D human lung cancer cell lines confirmed that PBK1 upregulated UPA expression by binding to the enhancer element.
Ma et al. (2008) found that overexpression of CSIG in 2BS fibroblasts promoted cell growth, increased the number of cells in S phase, and delayed senescence. In contrast, silencing of CSIG via small interfering RNA delayed cell growth, decreased the number of cells in S and G2/M phases, and accelerated cellular senescence. Reporter gene assays and Western blot analysis revealed that CSIG negatively regulated PTEN (601728) and its downstream effector p27(KIP1) (CDKN1B; 600778), both of which are required for replicative senescence. Binding studies showed that CSIG interacted with a specific segment of the PTEN 5-prime UTR, possibly indirectly, and downregulated PTEN translation, resulting in p27(KIP1) destabilization. Expression of PTEN was essential for CSIG-dependent expression of p27(KIP1) and cell cycle progression.
Wang et al. (2023) downregulated Rsl1d1 expression in fertilized mouse oocytes at the 2-pronuclei (2PN) stage. Almost all of the Rsl1d1 knockdown embryos were arrested at the morula stage compared to controls, and Rsl1d1 cRNA injection rescued the phenotype. The authors then generated mice with oocyte-specific knockout of Rsl1d1 and observed that homozygous females were completely infertile. Most oocytes from the homozygous female mice could be fertilized normally, and approximately 65% of zygotes could develop to the 2-cell stage, but few of those were able to progress to the 4-cell stage. The authors noted that this phenotype exactly recapitulated that of Kpna2 (see 614107) -/- female mice. Immunoprecipitation studies in HEK293T cells showed that RSL1D1 is a downstream substrate of mouse Kpna2 and its human homolog KPNA7 (614107), suggesting that both exert their function through RSL1D1 during embryonic development.
Ma, L., Chang, N., Guo, S., Li, Q., Zhang, Z., Wang, W., Tong, T. CSIG inhibits PTEN translation in replicative senescence. Molec. Cell. Biol. 28: 6290-6301, 2008. [PubMed: 18678645, images, related citations] [Full Text]
Tong, C., Tan, L., Li, P., Zhu, Y.-S. Identification of a novel nucleus protein involved in the regulation of urokinase in 95D cells. Acta Biochim. Biophys. Sin. (Shanghai) 37: 303-309, 2005. [PubMed: 15880258, related citations] [Full Text]
Wang, W., Miyamoto, Y., Chen, B., Shi, J., Diao, F., Zheng, W., Li, Q., Yu, L., Li, L., Xu, Y., Wu, L., Mao, X., and 20 others. Karyopherin alpha deficiency contributes to human preimplantation embryo arrest. J. Clin. Invest. 133: e159951, 2023. [PubMed: 36647821, images, related citations] [Full Text]
Alternative titles; symbols
HGNC Approved Gene Symbol: RSL1D1
Cytogenetic location: 16p13.13 Genomic coordinates (GRCh38) : 16:11,833,850-11,851,542 (from NCBI)
RSL1D1 is a nucleolar protein that regulates mRNA translation (Ma et al., 2008).
By suppressive subtractive hybridization to identify proteins downregulated with replicative senescence in 2BS human diploid fibroblasts, followed by PCR amplification, Ma et al. (2008) cloned RSL1D1, which they called CSIG. The deduced 490-amino acid protein has an N-terminal ribosomal L1 (see MRPL1, 611821) domain and a C-terminal lysine-rich domain. Northern blot analysis detected variable CSIG expression in most human tissues examined, with highest expression in heart, skeletal muscle, and placenta, and little to no expression in brain, colon, and thymus. Endogenous CSIG localized predominantly to the nucleolus in 2BS and HeLa cells and fractionated with HEK293 cell polysomes. Western blot analysis detected CSIG at an apparent molecular mass of 55 kD.
Ma et al. (2008) determined that the RSL1D1 gene contains 9 exons and spans 5.1 kb.
Ma et al. (2008) reported that the RSL1D1 gene maps to chromosome 16p13.
UPA (PLAU; 191840) is an extracellular matrix protease involved in cell migration. Using a yeast 1-hybrid screen and EMSA, Tong et al. (2005) found that RSL1D1, or PBK1, bound an enhancer region in the UPA promoter between 2 AP1 (see 165160) sites. Overexpression and knockdown experiments with 95D human lung cancer cell lines confirmed that PBK1 upregulated UPA expression by binding to the enhancer element.
Ma et al. (2008) found that overexpression of CSIG in 2BS fibroblasts promoted cell growth, increased the number of cells in S phase, and delayed senescence. In contrast, silencing of CSIG via small interfering RNA delayed cell growth, decreased the number of cells in S and G2/M phases, and accelerated cellular senescence. Reporter gene assays and Western blot analysis revealed that CSIG negatively regulated PTEN (601728) and its downstream effector p27(KIP1) (CDKN1B; 600778), both of which are required for replicative senescence. Binding studies showed that CSIG interacted with a specific segment of the PTEN 5-prime UTR, possibly indirectly, and downregulated PTEN translation, resulting in p27(KIP1) destabilization. Expression of PTEN was essential for CSIG-dependent expression of p27(KIP1) and cell cycle progression.
Wang et al. (2023) downregulated Rsl1d1 expression in fertilized mouse oocytes at the 2-pronuclei (2PN) stage. Almost all of the Rsl1d1 knockdown embryos were arrested at the morula stage compared to controls, and Rsl1d1 cRNA injection rescued the phenotype. The authors then generated mice with oocyte-specific knockout of Rsl1d1 and observed that homozygous females were completely infertile. Most oocytes from the homozygous female mice could be fertilized normally, and approximately 65% of zygotes could develop to the 2-cell stage, but few of those were able to progress to the 4-cell stage. The authors noted that this phenotype exactly recapitulated that of Kpna2 (see 614107) -/- female mice. Immunoprecipitation studies in HEK293T cells showed that RSL1D1 is a downstream substrate of mouse Kpna2 and its human homolog KPNA7 (614107), suggesting that both exert their function through RSL1D1 during embryonic development.
Ma, L., Chang, N., Guo, S., Li, Q., Zhang, Z., Wang, W., Tong, T. CSIG inhibits PTEN translation in replicative senescence. Molec. Cell. Biol. 28: 6290-6301, 2008. [PubMed: 18678645] [Full Text: https://doi.org/10.1128/MCB.00142-08]
Tong, C., Tan, L., Li, P., Zhu, Y.-S. Identification of a novel nucleus protein involved in the regulation of urokinase in 95D cells. Acta Biochim. Biophys. Sin. (Shanghai) 37: 303-309, 2005. [PubMed: 15880258] [Full Text: https://doi.org/10.1111/j.1745-7270.2005.00041.x]
Wang, W., Miyamoto, Y., Chen, B., Shi, J., Diao, F., Zheng, W., Li, Q., Yu, L., Li, L., Xu, Y., Wu, L., Mao, X., and 20 others. Karyopherin alpha deficiency contributes to human preimplantation embryo arrest. J. Clin. Invest. 133: e159951, 2023. [PubMed: 36647821] [Full Text: https://doi.org/10.1172/JCI159951]
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM